M. Silva, F. Portaels, and J. Pedrosa, Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer, The Lancet Infectious Diseases, vol.9, issue.11, pp.699-710, 2009.
DOI : 10.1016/S1473-3099(09)70234-8

D. Walsh, F. Portaels, and W. Meyers, Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection), Current Opinion in Infectious Diseases, vol.23, issue.5, pp.445-455, 2010.
DOI : 10.1097/QCO.0b013e32833c2209

S. Etuaful, B. Carbonnelle, J. Grosset, S. Lucas, and C. Horsfield, Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3182-3186, 2005.
DOI : 10.1128/AAC.49.8.3182-3186.2005

A. Chauty, M. Ardant, A. Adeye, H. Euverte, and A. Guedenon, Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease), Antimicrobial Agents and Chemotherapy, vol.51, issue.11, pp.4029-4035, 2007.
DOI : 10.1128/AAC.00175-07

P. Johnson, Should antibiotics be given for Buruli ulcer?, The Lancet, vol.375, issue.9715, pp.618-619, 2010.
DOI : 10.1016/S0140-6736(10)60169-9

F. Sarfo, R. Phillips, K. Asiedu, E. Ampadu, and N. Bobi, Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3678-3685, 2010.
DOI : 10.1128/AAC.00299-10

W. Nienhuis, Y. Stienstra, W. Thompson, P. Awuah, and K. Abass, Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial, The Lancet, vol.375, issue.9715, pp.664-672, 2010.
DOI : 10.1016/S0140-6736(09)61962-0

K. George, D. Chatterjee, G. Gunawardana, D. Welty, and J. Hayman, Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence, Science, vol.283, issue.5403, pp.854-857, 1999.
DOI : 10.1126/science.283.5403.854

H. Hong, C. Demangel, S. Pidot, P. Leadlay, and T. Stinear, Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Natural Product Reports, vol.45, issue.3, pp.447-454, 2008.
DOI : 10.1039/b803101k

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730631

C. Demangel, T. Stinear, and S. Cole, Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009.
DOI : 10.1093/molbev/msm092

F. Sarfo, R. Phillips, B. Rangers, E. Mahrous, and R. Lee, Detection of Mycolactone A/B in Mycobacterium ulcerans???Infected Human Tissue, PLoS Neglected Tropical Diseases, vol.2, issue.1, p.577, 2010.
DOI : 10.1371/journal.pntd.0000577.t001

H. Hong, E. Coutanceau, M. Leclerc, L. Caleechurn, and P. Leadlay, Mycolactone Diffuses from Mycobacterium ulcerans???Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs, PLoS Neglected Tropical Diseases, vol.23, issue.10, p.325, 2008.
DOI : 10.1371/journal.pntd.0000325.g006

T. Spangenberg and Y. Kishi, Highly sensitive, operationally simple, cost/time effective detection of the mycolactones from the human pathogen Mycobacterium ulcerans, Chemical Communications, vol.66, issue.9, pp.1410-1412, 2010.
DOI : 10.1039/b924896j

H. Hong, T. Stinear, P. Skelton, J. Spencer, and P. Leadlay, Structure elucidation of a novel family of mycolactone toxins from the frog pathogen Mycobacterium sp. MU128FXT by mass spectrometry, Chem Commun, vol.14, pp.4306-4308, 2005.

R. Phillips, F. Sarfo, L. Guenin-mace, J. Decalf, and M. Wansbrough-jones, Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease, The Journal of Infectious Diseases, vol.200, issue.11, pp.1675-84, 2009.
DOI : 10.1086/646615

URL : https://hal.archives-ouvertes.fr/pasteur-01402286

F. Sarfo, R. Phillips, E. Ampadu, F. Sarpong, and E. Adentwe, Dynamics of the Cytokine Response to Mycobacterium ulcerans during Antibiotic Treatment for M. ulcerans Disease (Buruli Ulcer) in Humans, Clinical and Vaccine Immunology, vol.16, issue.1, pp.61-65, 2009.
DOI : 10.1128/CVI.00235-08

D. Yeboah-manu, E. Peduzzi, E. Mensah-quainoo, A. Asante-poku, and D. Ofori-adjei, Systemic suppression of interferon-?? responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, Journal of Leukocyte Biology, vol.79, issue.6, pp.1150-1156, 2006.
DOI : 10.1189/jlb.1005581

M. Beissner, K. Herbinger, and G. Bretzel, Laboratory diagnosis of Buruli ulcer disease, Future Microbiology, vol.5, issue.3, pp.363-370, 2010.
DOI : 10.2217/fmb.10.3

T. Callaway, R. Anderson, T. Edrington, Y. Jung, and K. Bischoff, Effects of sodium chlorate on toxin production by Escherichia coli O157:H7, Curr Issues Intest Microbiol, vol.5, pp.19-22, 2004.

C. Gordon, J. Buntine, J. Hayman, C. Lavender, and J. Fyfe, All-Oral Antibiotic Treatment for Buruli Ulcer: A Report of Four Patients, PLoS Neglected Tropical Diseases, vol.189, issue.11, p.770, 2010.
DOI : 10.1371/journal.pntd.0000770.t001

A. Pahlevan, D. Wright, C. Andrews, K. George, and P. Small, The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function, J Immunol, vol.163, pp.3928-3935, 1999.

S. Boulkroun, L. Guenin-mace, M. Thoulouze, M. Monot, and A. Merckx, Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events, The Journal of Immunology, vol.184, issue.3, pp.1436-1444, 2010.
DOI : 10.4049/jimmunol.0902854

URL : https://hal.archives-ouvertes.fr/pasteur-00594632

E. Coutanceau, J. Decalf, A. Martino, A. Babon, and N. Winter, toxin mycolactone, The Journal of Experimental Medicine, vol.22, issue.6, pp.1395-1403, 2007.
DOI : 10.1016/0022-1759(94)90236-4

URL : https://hal.archives-ouvertes.fr/pasteur-01402321

E. Coutanceau, L. Marsollier, R. Brosch, E. Perret, and P. Goossens, Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cellular Microbiology, vol.34, issue.8, pp.1187-1196, 2005.
DOI : 10.1016/S0140-6736(99)01156-3

R. Simmonds, F. Lali, T. Smallie, P. Small, and B. Foxwell, Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism, The Journal of Immunology, vol.182, issue.4, pp.2194-2202, 2009.
DOI : 10.4049/jimmunol.0802294

D. Schutte and G. Pluschke, infection (Buruli ulcer), Expert Opinion on Biological Therapy, vol.162, issue.2, pp.187-200, 2009.
DOI : 10.1038/sj.cdd.4401168